Diamyd Medical AB (publ) (DMYD-B.ST)

SEK 8.24

(-2.94%)

Eps Summary of Diamyd Medical AB (publ)

  • Diamyd Medical AB (publ)'s latest annual eps in 2024 was -1.60 SEK , down -8.11% from previous year.
  • Diamyd Medical AB (publ)'s latest quarterly eps in 2024 Q2 was -0.31 SEK , up 16.22% from previous quarter.
  • Diamyd Medical AB (publ) reported an annual eps of -1.48 SEK in 2023, down -30.97% from previous year.
  • Diamyd Medical AB (publ) reported an annual eps of -1.13 SEK in 2022, down -140.65% from previous year.
  • Diamyd Medical AB (publ) reported a quarterly eps of -0.41 SEK for 2024 Q3, down -32.26% from previous quarter.
  • Diamyd Medical AB (publ) reported a quarterly eps of -0.31 SEK for 2024 Q2, up 16.22% from previous quarter.

Annual Eps Chart of Diamyd Medical AB (publ) (2024 - 2010)

Historical Annual Eps of Diamyd Medical AB (publ) (2024 - 2010)

Year Eps Eps Growth
2024 -1.60 SEK -8.11%
2023 -1.48 SEK -30.97%
2022 -1.13 SEK -140.65%
2021 2.78 SEK 1885.71%
2020 0.14 SEK 125.45%
2019 -0.55 SEK 29.49%
2018 -0.78 SEK -5.41%
2017 -0.74 SEK 32.73%
2016 -1.10 SEK -37.5%
2015 -0.80 SEK -26.98%
2014 -0.63 SEK 19.23%
2013 -0.78 SEK 78.27%
2012 -3.59 SEK -243.6%
2011 2.50 SEK 29169.77%
2010 -0.01 SEK 0.0%

Peer Eps Comparison of Diamyd Medical AB (publ)

Name Eps Eps Difference
Active Biotech AB (publ) -0.17 SEK -841.176%
Amniotics AB (publ) -0.01 SEK -14445.455%
BioArctic AB (publ) 2.60 SEK 161.538%
Calliditas Therapeutics AB (publ) -8.69 SEK 81.588%
Camurus AB (publ) 7.78 SEK 120.566%
Cantargia AB (publ) -1.65 SEK 3.03%
Scandinavian ChemoTech AB (publ) -1.13 SEK -41.593%
CombiGene AB (publ) -1.80 SEK 11.111%
Genovis AB (publ.) 0.94 SEK 270.213%
Guard Therapeutics International AB (publ) -11.26 SEK 85.79%
Mendus AB (publ) -4.40 SEK 63.636%
Isofol Medical AB (publ) -0.23 SEK -595.652%
Intervacc AB (publ) -1.69 SEK 5.325%
Kancera AB (publ) -0.80 SEK -100.0%
Karolinska Development AB (publ) 0.02 SEK 8100.0%
LIDDS AB (publ) -0.63 SEK -153.968%
Lipum AB (publ) -4.45 SEK 64.045%
Lipigon Pharmaceuticals AB (publ) -0.19 SEK -742.105%
Magle Chemoswed Holding AB (publ) 1.13 SEK 241.593%
NextCell Pharma AB -1.03 SEK -55.34%
OncoZenge AB (publ) -1.36 SEK -17.647%
Saniona AB (publ) -1.29 SEK -24.031%
Simris Alg AB (publ) -0.16 SEK -900.0%
Vicore Pharma Holding AB (publ) -3.22 SEK 50.311%
Xbrane Biopharma AB (publ) -1.27 SEK -25.984%
Xintela AB (publ) -0.13 SEK -1130.769%
Xspray Pharma AB (publ) -6.76 SEK 76.331%
Ziccum AB (publ) -1.54 SEK -3.896%
Asarina Pharma AB (publ) -0.57 SEK -180.702%
Elicera Therapeutics AB (publ) -0.83 SEK -92.771%
Modus Therapeutics Holding AB (publ) -1.01 SEK -58.416%
Alligator Bioscience AB (publ) -0.55 SEK -190.909%
Sprint Bioscience AB (publ) -0.01 SEK -25296.825%
QuiaPEG Pharmaceuticals Holding AB (publ) -0.22 SEK -627.273%
Corline Biomedical AB -0.08 SEK -1800.238%
IRLAB Therapeutics AB (publ) -3.43 SEK 53.353%
Bio-Works Technologies AB (publ) -1.57 SEK -1.911%
Aptahem AB (publ) -0.05 SEK -3212.629%
Infant Bacterial Therapeutics AB (publ) -9.95 SEK 83.92%
Fluicell AB (publ) -0.24 SEK -566.667%
Biovica International AB (publ) -2.14 SEK 25.234%
Spago Nanomedical AB (publ) -0.43 SEK -272.093%
AcouSort AB (publ) -1.29 SEK -24.031%
Abliva AB (publ) -0.09 SEK -1669.912%
Egetis Therapeutics AB (publ) -1.27 SEK -25.984%
2cureX AB (publ) -1.85 SEK 13.514%
I-Tech AB 1.70 SEK 194.118%
Hansa Biopharma AB (publ) -15.83 SEK 89.893%
Cyxone AB (publ) -0.22 SEK -627.273%
ExpreS2ion Biotech Holding AB (publ) -1.98 SEK 19.192%
Biosergen AB -0.60 SEK -166.667%
Nanologica AB (publ) -2.05 SEK 21.951%
SynAct Pharma AB -6.64 SEK 75.904%
Annexin Pharmaceuticals AB (publ) -0.26 SEK -515.385%
BioInvent International AB (publ) -5.02 SEK 68.127%
Stayble Therapeutics AB (publ) -0.92 SEK -73.913%
Alzinova AB (publ) -0.41 SEK -290.244%
Oncopeptides AB (publ) -1.96 SEK 18.367%
Pila Pharma AB (publ) -0.47 SEK -240.426%
Ascelia Pharma AB (publ) -3.24 SEK 50.617%
Diagonal Bio AB (publ) -0.32 SEK -400.0%